SWP
EW icon

Sagespring Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Sagespring Wealth Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
11,515
+13
+0.1% +$1.09K 0.02% 341
2026
Q1 		$921K Buy
11,502
+930
+9% +$76.7K 0.02% 342
2025
Q4 		$901K Buy
10,572
+245
+2% +$20.1K 0.02% 326
2025
Q3 		$803K Sell
10,327
-202
-2% -$15.8K 0.02% 346
2025
Q2 		$823K Buy
10,529
+469
+5% +$35K 0.02% 323
2025
Q1 		$729K Sell
10,060
-1,185
-11% -$84.8K 0.02% 305
2024
Q4 		$832K Buy
+11,245
New +$787K 0.02% 248

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sagespring Wealth Partners's EW Position: Q2 2026 in Review

Sagespring Wealth Partners increased its Edwards Lifesciences (EW) stake by 0.11% in Q2 2026, buying an estimated $1.09K and bringing the position to 11,515 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #341.

Sagespring Wealth Partners first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sagespring Wealth Partners held 11,515 shares of Edwards Lifesciences worth $1.04M as of Q2 2026.
  • Sagespring Wealth Partners bought 13 Edwards Lifesciences shares in Q2 2026, an estimated $1.09K.
  • Edwards Lifesciences made up 0.02% of Sagespring Wealth Partners's portfolio in Q2 2026, its #341 holding.
  • Sagespring Wealth Partners first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.